Boston already has a proven track record of life science leadership, including emerging therapeutics. Digital technologies will play a critical role in the expansion of this industry and are poised to grow by more than $350 billion alone in the next five years, but significant scientific, technological, financial, and regulatory challenges remain in expanding the ecosystem.
Xcelerating Life Sciences Boston will look at what’s already been accomplished and how to handle the hurdles that lie ahead for this shift in focus toward digital health. Discover how you can be part of this growing community, how your past successes can be applied to the evolving market, and what resources in your backyard you can utilize.
Learn what's fueling Boston's biotech investment and partnership opportunities during this digital health revolution by registering your team to attend Xcelerating Life Sciences: Biopharma’s Future in Digital Health on May 13, 2020.
CEO & Founder, Empiriko
Chief Business Officer, MassBio
Joris Van Dam
Head of Digital Therapeutics, Novartis Institutes for BioMedical Research
CEO & Founder, Health Innovation Strategies
CEO & Founder, Olaris, Inc.
COO & Co-founder, Voluntis
Senior Director, Head of Portfolio Delivery & Operations, Digital & Quantitative Medicine - Biogen
Chief Strategy Officer, Pear Therapeutics